| The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer | |
| Wang, Lingfei; Yu, Xiaojie; Wang, Chao; Pan, Shujun; Liang, Beibei; Zhang, Yajun; Chong, Xiaodan; Meng, Yanchun; Dong, Jian; Zhao, Yirong | |
| 刊名 | ONCOTARGET
 |
| 2017 | |
| 卷号 | 8期号:32 |
| 关键词 | trastuzumab resistance GDC-0941 anti-ErbB2 antibody programmed cell death breast cancer |
| ISSN号 | 1949-2553 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4268483 |
| 专题 | 上海健康医学院 |
| 推荐引用方式 GB/T 7714 | Wang, Lingfei,Yu, Xiaojie,Wang, Chao,et al. The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer[J]. ONCOTARGET,2017,8(32). |
| APA | Wang, Lingfei.,Yu, Xiaojie.,Wang, Chao.,Pan, Shujun.,Liang, Beibei.,...&Li, Bohua.(2017).The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer.ONCOTARGET,8(32). |
| MLA | Wang, Lingfei,et al."The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer".ONCOTARGET 8.32(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论